“…In this context, peptides and peptidomimetics are elective compounds ( Scognamiglio et al, 2013 ; Carotenuto et al, 2014 ; La Manna et al, 2018a ): they act as proteomimetics able to selectively recognize their target protein in biophysical assays and to mimic, totally or partially, the cellular function of native proteins ( Lonardo et al, 2010 ; Causa et al, 2013 ; Sawyer et al, 2017 ). A prominent strategy, mostly lying on the knowledge of the structure of protein complex, consists in the identification of isolated protein fragments mainly responsible for the formation of the protein complex and successively on their conformational stabilization through covalent restraints to improve the affinity and stabilities of unstructured peptides for target proteins ( Russo et al, 2015 ; Soler et al, 2017 ; Adedeji Olulana et al, 2021 ; La Manna et al, 2021 ). In this scenario, several structure-based inhibitors demonstrated discrete success.…”